JOINT FILING AGREEMENTJoint Filing Agreement • November 23rd, 2020 • Avista Capital Partners III GP, L.P. • Pharmaceutical preparations
Contract Type FiledNovember 23rd, 2020 Company IndustryThis Joint Filing Agreement may be executed in separate counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.
LETTER AGREEMENTLetter Agreement • November 23rd, 2020 • Avista Capital Partners III GP, L.P. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 23rd, 2020 Company Industry JurisdictionThis LETTER AGREEMENT (this “Agreement”) is entered into on November 19, 2020, by and among Avista Capital Partners III GP, L.P. (“Avista”), Osmotica Pharmaceuticals plc (“Osmotica”), Orbit Co-Invest I, LLC (“Orbit I”), SDK VC Pharma Holding Corp. (“SDK”), and Steven Squashic, Kevin Hudy and David Purdy (collectively, the “SDK Shareholders” and, together with SDK, the “SDK Parties”, and together with Avista and Osmotica, the “Parties”)).